Text: H01603 Text: H01605 Text: H01600 - H01699 Text: H Index Bills and Amendments: General Index Bill History: General Index
PAG LIN
1 1 Amend House File 715 as follows:
1 2 #1. Page 15, by striking lines 21 and 22 and
1 3 inserting the following:
1 4 "1. a. The department shall continue prospective
1 5 drug utilization review and may establish drug
1 6 surveillance prior authorization under the medical
1 7 assistance program. The department shall also conduct
1 8 a prior authorization cost-effectiveness review study
1 9 and shall not include in the study any individual
1 10 currently or previously utilized for a similar study
1 11 by the department.
1 12 b. The prospective drug utilization review and
1 13 prior authorization review studies shall include, but
1 14 are not limited to, all of the following:
1 15 (1) The net cost of the generic substitution and
1 16 brand-name drugs denied under prior authorization,
1 17 including the effect of rebates.
1 18 (2) The costs attributed to cost-shifting to more
1 19 expensive treatment regimens, including additional
1 20 physician visits, emergency room visits,
1 21 hospitalization, and nursing home placements.
1 22 (3) The cost of prescribing mandates, such as
1 23 requiring two failures of generic drug treatment
1 24 before allowing prescribing of a brand-name
1 25 alternative.
1 26 (4) Outcomes measures of cost-effectiveness and
1 27 comparison of the two approaches.
1 28 (5) Administrative costs and comparison of the two
1 29 approaches.
1 30 c. Beginning April 1, 1998, the department shall
1 31 remove from the categories of prescription drugs, for
1 32 which prior authorization is currently necessary, all
1 33 of the following for which the comparative drug usage
1 34 studies establish that prospective drug utilization
1 35 review is at least as cost-effective as prior
1 36 authorization:
1 37 (1) Nonsedating antihistamines.
1 38 (2) Histamine H2-receptor antagonists.
1 39 (3) Cephalexin hydrochloride monohydrate
1 40 prescriptions.
1 41 (4) Single-source nonsteroidal anti-inflammatory
1 42 drugs.
1 43 (5) Single-source benzodiazepines.
1 44 (6) Topical acne products.
1 45 (7) Proton pump inhibitors.
1 46 d. The department may adopt emergency rules to
1 47 implement this subsection."
1 48
1 49
1 50
2 1 BLODGETT of Cerro Gordo
2 2
2 3
2 4
2 5 HANSEN of Pottawattamie
2 6 HF 715.702 77
2 7 pf/sc/28
Text: H01603 Text: H01605 Text: H01600 - H01699 Text: H Index Bills and Amendments: General Index Bill History: General Index
Iowa General Assembly
Search: House Bills and Amendments (77th General Assembly)
© 1997 Cornell College and League of Women Voters of Iowa
Comments about this site or page? webmaster@legis.iowa.gov. Please remember that the person listed above does not vote on bills. Direct all comments concerning legislation to State Legislators.
Last update: Wed Apr 9 03:43:12 CDT 1997
URL: /DOCS/GA/77GA/Legislation/H/01600/H01604/970408.html
jhf